Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
12/05/2007 | CN101084014A Single domain antibodies against tnfr1 and methods of use therefor |
12/05/2007 | CN101084013A Cancerous disease modifying antibodies |
12/05/2007 | CN101084012A Methods of treating cancer using il-21 and monoclonal antibody therapy |
12/05/2007 | CN101084011A Porcine reproductive and respiratory syndrome virus strains and compositions |
12/05/2007 | CN101084010A Vaccines against japanese encephalitis virus and west nile virus |
12/05/2007 | CN101083907A Compositions and methods for topical diagnostic and therapeutic transport |
12/05/2007 | CN101082051A Recombined foot-and-mouth disease virus polypeptide fragment and and uses thereof |
12/05/2007 | CN101082041A Novel vaccinia virus strain, vaccinia live attenuated vaccine and preparation method thereof |
12/05/2007 | CN101081869A Humanized antibodies that recognize beta amyloid peptide |
12/05/2007 | CN101081868A Humanized antibodies that recognize beta amyloid peptide |
12/05/2007 | CN101081867A Humanized antibodies that recognize beta amyloid peptide |
12/05/2007 | CN101081866A Domestic animal and aquatic product causal agent resistant specific IgY or compound IgY and application thereof |
12/05/2007 | CN101081863A Lipopolysaccharide conjugated protein and monoclonal antibody and preparation method and usage |
12/05/2007 | CN101081299A Yelk immune globulin products for preventing and treating bainite cryptosporidiosis and application thereof |
12/05/2007 | CN101081298A Method for preparation of novel subunit vaccine for treating porcine pseudorabies |
12/05/2007 | CN101081297A Fowl multi-killed pasteurellosis bacillus live vaccine |
12/05/2007 | CN101081296A Method for preparing b type haemophilus influenzae capsular polysaccharide and united vaccines thereof |
12/05/2007 | CN100352930C Vaccines immunotherapeutics and method for using the same |
12/05/2007 | CN100352924C BASB 111 polypeptide and polynucleotide from moraxella cathraahalis |
12/05/2007 | CN100352921C Compositions and methods for identifying antigens which elicit an immune response |
12/05/2007 | CN100352918C Cellular immunogenicity potentiating composition containing alpha-glycosylceramide |
12/05/2007 | CN100352844C Recombinant anti-osteopontin antibody and use thereof |
12/05/2007 | CN100352843C Kdr peptides and vaccines comprising the same |
12/05/2007 | CN100352513C Novel mucous membrane vaccine for newcastle disease and its construction method |
12/05/2007 | CN100352502C Recombinant protein and recombinant gene capable of preventing and curing I type diabetes mellitus through immunity |
12/05/2007 | CN100352501C Cripto blocking antibodies and uses thereof |
12/05/2007 | CN100352500C Stable liquid formulations of antibodies |
12/05/2007 | CN100352497C Antibody inhibition body fluid immunity of using special integrated CD40CR(CD40 part) |
12/05/2007 | CN100352427C Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
12/04/2007 | US7304151 Useful in vaccine effective against Mannheimia haemolytica in animals |
12/04/2007 | US7304142 Mammalian MDM2 binding proteins |
12/04/2007 | US7304139 Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same |
12/04/2007 | US7304135 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
12/04/2007 | US7303926 Causing necrosis or apoptosis of target tissue using both type 1 and type 2 mechanisms |
12/04/2007 | US7303911 Useful as vaccine for the treatment of prostate cancer especially with a vaccine adjuvant which may include Il-2, IL-12, interferon gamma, BCG, tetanus toxoid or Mycobacterium Vaccae. |
12/04/2007 | US7303896 Nucleic acid encoding novel type-1 cytokine receptor GLM-R |
12/04/2007 | US7303885 For treating or detecting MIF (macrophage migration inhibitor factor) related diseases by detecting MIF/Jab1 (c-Jun activation domain binding protein) interactions; complex MIF in natural association with Jab1 and optionally another protein |
12/04/2007 | US7303754 MVA expressing modified HIV envelope, gag, and pol genes |
12/04/2007 | US7303752 Treating infection to increase lymphocyte proliferation with cocktail of recombinant or synthetic antigens derived from hookworm, or chemically treated hookworm; tuberculosis, malaria, measles, tetanus, diphtheria, pertussis, polio; human T-cell leukemia/lymphoma and/or lymphadenopathy associated virus |
12/04/2007 | US7303751 P. falciparum erythrocyte binding protein-2 (EBP2) Region II (RII), used to induce an immune response to Plasmodium falciparum merozoites to treat diseases such as malaria |
12/04/2007 | US7303750 Methods to improve immunogenicity of antigens and specificity of antibodies |
12/04/2007 | US7303749 Immunoconjugate of a maytansine linked to a monoclonal antibody that binds to an antigen expressed by a cancer cell, and a taxane, an epothilone, a platinum compound, an epipodophyllotoxin, and/or a camptothecin |
12/04/2007 | US7303747 Use of VEGF inhibitors for treatment of eye disorders |
12/04/2007 | US7302913 Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells |
12/04/2007 | CA2310677C In vitro and in vivo growth-promoting proteins and peptides for kidney epithelial cells |
12/04/2007 | CA2283295C Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
12/04/2007 | CA2224724C Subunit vaccine against flavivirus infection |
12/04/2007 | CA2201120C Polyethylene glycol modified ceramide lipids and liposome uses thereof |
12/04/2007 | CA2140878C Interleukin-4 stimulated t lymphocyte cell death |
12/04/2007 | CA2121241C Porcine reproductive respiratory syndrome vaccine and diagnostic |
11/29/2007 | WO2007137279A2 Herv-k antigens, antibodies, and methods |
11/29/2007 | WO2007137275A2 Stimulators of osteoblastogenesis and applications of the same |
11/29/2007 | WO2007137235A2 Apparatus, methods and systems for toxin delivery to the nasal cavity |
11/29/2007 | WO2007137170A2 Anti-glypican-3 antibody drug conjugates |
11/29/2007 | WO2007136882A2 Radiating element for radar array antenna |
11/29/2007 | WO2007136778A2 Fusion proteins, uses thereof and processes for producing same |
11/29/2007 | WO2007136679A2 Targeting vegf-b regulation of fatty acid transporters to modulate human diseases |
11/29/2007 | WO2007136585A2 Immunotherapeutic compositions and methods |
11/29/2007 | WO2007136525A2 Chimeric monoclonal antibody |
11/29/2007 | WO2007135992A1 Cerebral vasospasm inhibitor |
11/29/2007 | WO2007135546A2 TREATMENT OF CANCER WITH ANTI-IL-1α ANTIBODIES |
11/29/2007 | WO2007135542A2 Progastrin inhibitors in the treatment of colon cancer |
11/29/2007 | WO2007135425A1 Stable vaccine formulation |
11/29/2007 | WO2007135401A2 Method for producing regulatory t cells by costimulating cd55 and cd3 |
11/29/2007 | WO2007135390A1 Prevention of plaque formation |
11/29/2007 | WO2007135385A1 Chemically defined culture medium for neisseria |
11/29/2007 | WO2007134538A1 Rat antihuman macrophage migration inhibitory factor monoclonal antibody and its application |
11/29/2007 | WO2007134385A1 Immunogenic compositions |
11/29/2007 | WO2007134350A2 Antibodies specific for bet v 1 and use thereof in the prevention and treatment of bet v 1-induced diseases |
11/29/2007 | WO2007113222A3 Immunogenic composition |
11/29/2007 | WO2007113172A3 Antibodies against amyloid-beta peptide |
11/29/2007 | WO2007111931A3 Compositions and methods relating to modulation of immune system components |
11/29/2007 | WO2007109823A3 Peptide library |
11/29/2007 | WO2007106744A3 Anti-5t4 antibodies and uses thereof |
11/29/2007 | WO2007103288A3 Engineered antibody drug conjugates |
11/29/2007 | WO2007103112A3 Methods of treating inflammatory and autoimmune diseases with natalizumab |
11/29/2007 | WO2007097810A3 Treatment for antiphospholipid-syndrome-related pregnancy complications |
11/29/2007 | WO2007090872A3 Antibodies against secreted fri zzled related protein-4 (sfrp-4 ) |
11/29/2007 | WO2007084583A3 Soluble fragments of the sars-cov spike glycoprotein |
11/29/2007 | WO2007081978A3 Modulators of hepatocyte growth factor / c-met activity |
11/29/2007 | WO2007081966A3 Small molecules for treating cancer and abnormal cell proliferation disorders |
11/29/2007 | WO2007081938A3 Mannheimia haemolytica chimeric outer membrane protein plpe and leukotoxin epitopes as a vaccine or vaccine component against shipping fever |
11/29/2007 | WO2007080392A3 Ligands that have binding specificity for vegf and/or egfr and methods of use therefor |
11/29/2007 | WO2007071710A3 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
11/29/2007 | WO2007070432A3 Binding proteins specific for insulin-like growth factors and uses thereof |
11/29/2007 | WO2007068750A3 Immunoglobulins directed against nogo |
11/29/2007 | WO2007067992A3 Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1 |
11/29/2007 | WO2007067959A3 Ctla-4 antibody dosage escalation regimens |
11/29/2007 | WO2007052168A3 Fed batch culture methods for streptococci |
11/29/2007 | WO2007051036A8 Influenza combinatorial antigen vaccine |
11/29/2007 | WO2007048107A3 Proteomic profiling of mast cell tumors and related methods, proteins and nucleic acid molecules |
11/29/2007 | WO2007047967A3 Detoxification depot for alzheimer's disease |
11/29/2007 | WO2007038453A3 Use of an anti-vascular endothelial growth factor (vegf) agent to ameliorate inflammation |
11/29/2007 | WO2007022151A3 Immunization of avians by administration of non-replicating vectored vaccines |
11/29/2007 | WO2006138745A3 Therapeutic peptides and vaccines |
11/29/2007 | WO2006050075A3 Method of increasing efficacy of tumor cell killing using combinations of anti-neoplastic agents |
11/29/2007 | WO2004078022A3 Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues |
11/29/2007 | WO2004037202A3 Gb virus c and methods of treating viral infections |
11/29/2007 | US20070276037 Cytoprotective Effects of Ethyl Pyruvate |
11/29/2007 | US20070275895 Inhibiting proliferation of immune cells in leukemia comprising administering an antibody that specifically binds a follistatin-3 polypeptide; inhibiting B cell or T cell proliferation |